Research Square

Death risk differed by site of osteoporosis-related fractures

Among 4,773 patients, estimated five-year mortality was 17.64%, compared with an 8.41% risk of a first repeat fracture.

Paper by Jintao Xi, Tao Li, Biwang Huang, 4 more authorsHang He · Wuhan Integrated Traditional Chinese and Western Medicine Orthopedic Hospital
Figure 2. Absolute risks of mortality and first refracture after osteoporotic fracture.
Open the figure at full size
Figure 2. Absolute risks of mortality and first refracture after osteoporotic fracture.Absolute risks of mortality and first refracture after osteoporotic fracture.Xi et al.
Preprint: cohort study of 4,773 patients with osteoporotic fracturesBiomarkers

Independent replication

Limit: Incompletely recorded frailty and functional status could confound mortality differences between fracture sites

Edited by Boris Djordjevic · AgingResearch.News

Follow

Researchers conducted a retrospective observational study of 4,773 patients hospitalized with osteoporotic fractures, or fractures related to weakened bones. They also tested a prediction model in an independent hospital cohort of 695 patients.

In the development cohort, estimated five-year mortality was highest after hip or thighbone fractures, at 32.10%. Female sex was associated with lower mortality but higher repeat-fracture risk. The researchers built a model using nine patient characteristics to estimate the risk of death within 365 days after discharge. Applied without changes to the independent cohort, its overall predictions closely matched the observed mortality. Twenty of that cohort’s 28 deaths (71.4%) occurred among the fifth of patients with the highest predicted risk.

Why it matters

For osteoporosis, an age-related bone disease, the authors suggested that the model may provide a practical basis for grouping patients by mortality risk after a fracture.

Caveats

External validation included only 28 deaths in one hospital cohort, limiting the evidence for performance elsewhere. This preprint has not been peer-reviewed, and the authors called for evaluation in broader clinical settings.

From the paper

Participants

The development cohort comprised 4,773 patients with osteoporotic fractures reconstructed from a publicly released longitudinal dataset.

Methods

Result

Female sex was associated with lower mortality (HR, 0.64; 95% CI, 0.54–0.76) but higher refracture risk (cause-specific HR, 1.47; 95% CI, 1.09–1.98; Fine–Gray sHR, 1.54; 95% CI, 1.14–2.08).

Results

Limitation

Both the development and external validation cohorts were retrospective, and residual confounding, misclassification, and incomplete capture of clinical information remain possible.

Strengths and limitations

Quoted word for word from the full text on researchsquare.com.

Comments

Be the first to comment.